Literature DB >> 15280728

Surgical outcomes in patients with endolymphatic sac tumors.

Marlan R Hansen1, William M Luxford.   

Abstract

OBJECTIVE: To determine the surgical outcomes in patients with endolymphatic sac tumors (ELSTs). STUDY
DESIGN: Retrospective review of patients at a referral-based otology-neurotology practice.
METHODS: A review of the records from the House Ear Clinic revealed 16 patients treated for ELSTs from 1971 to 2002. This article reports the treatment outcomes for the 14 patients for whom clinical data were available.
RESULTS: Sensorineural hearing loss, tinnitus, and dizziness were the most common presenting signs and symptoms. Six patients presented with facial weakness, and three patients had symptoms characteristic of Menière's syndrome. One patient suffered from Von Hippel-Lindau disease. Patients underwent microsurgical removal and were followed for an average of 59.6 months. Patients that presented with normal facial function maintained excellent postoperative function, and hearing was preserved in two patients with small tumors. Two patients suffered persistent, progressive disease despite multiple attempts at microsurgical removal and radiotherapy. Both had incomplete resections of their initial tumors. A third patient developed a small recurrent tumor that was successfully managed by a second attempt at microsurgical removal.
CONCLUSIONS: Taken together with other reports, these results suggest that ELSTs are best managed by complete surgical resection. This can generally be accomplished with minimal additional morbidity.

Entities:  

Mesh:

Year:  2004        PMID: 15280728     DOI: 10.1097/00005537-200408000-00028

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

1.  The endolymphatic sac tumor: challenges in the eradication of a localized disease.

Authors:  Vittoria Sykopetrites; Gianluca Piras; Annalisa Giannuzzi; Antonio Caruso; Abdelkader Taibah; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-05       Impact factor: 2.503

Review 2.  Von Hippel-Lindau disease: a single gene, several hereditary tumors.

Authors:  J Crespigio; L C L Berbel; M A Dias; R F Berbel; S S Pereira; D Pignatelli; T L Mazzuco
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

3.  Surgical management of endolymphatic sac tumors.

Authors:  Rick A Friedman; Michael Hoa; Derald E Brackmann
Journal:  J Neurol Surg B Skull Base       Date:  2012-11-09

4.  Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications.

Authors:  H Jeffrey Kim; Marygrace Hagan; John A Butman; Martin Baggenstos; Carmen Brewer; Christopher Zalewski; W Marston Linehan; Russell R Lonser
Journal:  Laryngoscope       Date:  2012-10-15       Impact factor: 3.325

5.  Sporadic endolymphatic sac tumor--a diagnostic and therapeutic challenge.

Authors:  Julian Künzel; Abbas Agaimy; Joachim Hornung; Michael Lell; Oliver Ganslandt; Sabine Semrau; Johannes Zenk
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Tumors and pseudotumors of the endolymphatic sac.

Authors:  Rodney C Diaz; Esmael H Amjad; Eric W Sargent; Michael J Larouere; Wayne T Shaia
Journal:  Skull Base       Date:  2007-11

7.  Treatment of endolymphatic sac tumour (Papillary adenocarcinoma) of the temporal bone.

Authors:  Arturo Mario Poletti; Siba Prasad Dubey; Giovanni Colombo; Giovanni Cugini; Antonio Mazzoni
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-30

8.  Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies.

Authors:  E Zanoletti; L Girasoli; D Borsetto; G Opocher; A Mazzoni; A Martini
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

9.  Gamma knife radiosurgery in the management of endolymphatic sac tumors.

Authors:  Georges Sinclair; Yehya Al-Saffar; Marina Brigui; Heather Martin; Jessica Bystam; Hamza Benmakhlouf; Alia Shamikh; Ernest Dodoo
Journal:  Surg Neurol Int       Date:  2018-01-25

10.  Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndrome.

Authors:  Thomas Nelson; Jethro Hu; Serguei Bannykh; Xuemo Fan; Jeremy Rudnick; Eric Vail
Journal:  CNS Oncol       Date:  2020-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.